Thiostrepton suppresses rhabdomyosarcoma progression by targeting the PI3K–AKT pathway Post author:admin Post published: October 30, 2025 Post category:uncategorized Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. You Might Also Like Their first baby came with medical debt. These Illinois parents won’t have another. May 10, 2024 Novel light-sensitive drug induces sleep without genetic modification May 28, 2024 Stress and pain linked to worse outcomes in HER2-positive breast cancer patients June 2, 2024